CClinicalTrials.gg
RecruitingNCT07179406Updated Jun 26, 2026

The Effect of Spinal Cord Stimulators on Restless Leg Syndrome

An interventional study of H-Reflex and Somatosensory evoked potential (SSEP) in Restless Leg Syndrome (RLS) and Spinal Cord Stimulation (SCS), sponsored by University of Alabama at Birmingham. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-26.

Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Aug 2025; still recruiting 1 year 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to evaluate neurophysiological responses and symptom changes in individuals with Restless Legs Syndrome (RLS) and/or chronic pain. Participants will undergo standard clinical assessments including EEG, EMG, h-reflex, SSEP, ERP, and TMS under varying SCS conditions.The study involves 4 arms. Arm 1 are individuals diagnosed with RLS and Healthy Controls. Arm 2 are individuals diagnosed with RLS and have an existing SCS. Arm 3 are individuals diagnosed with RLS and scheduled to receive a SCS. Arm 4 are individuals with chronic pain and have a SCS, but no diagnosis of RLS.

02

Conditions studied

  • Restless Leg Syndrome (RLS)
  • Spinal Cord Stimulation (SCS)

Keywords

  • SCS
  • Spinal Cord Stimulation
  • RLS
  • Restless Leg Syndrome
03

In context

Restless Legs Syndrome

248 studies on the registry are indexed under Restless Legs Syndrome; 39 are open to participants now.

This study's planned enrollment of 50 is close to the median of 53 across 196 interventional studies indexed under Restless Legs Syndrome.

Browse Restless Legs Syndrome studies →

Lead sponsor

University of Alabama at Birmingham is the lead sponsor of 1,396 studies on the registry; 284 are open to participants now.

Of its 156 completed or terminated interventional studies of FDA-regulated products, 124 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Has Restless Leg Syndrome
  • No major changes in RLS medications in past 4 weeks
  • Willing and able to comply with study protocol
  • Healthy Controls - No RLS diagnosis
  • Ability to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Any mental or physical limitation that would prevent completing any of the studies
  • Currently using another device to treat RLS
  • Unable or unwilling to comply with study protocols
  • Other medical condition that would put the subject at risk as determined by the investigator
  • Pregnant, breastfeeding, or trying to become pregnant
  • Currently participating or planning to participate in any other investigational clinical evaluation during the study period that may, in the opinion of the investigator, affect RLS
  • One or more of the following diseases: spinal cord injury, severe peripheral neuropathy or radiculopathy, severe psychiatric or cognitive disorder that may interfere with participation of the study, history of drug or alcohol abuse within the past year, epilepsy or seizure disorder, current active or chronic infection other than the common cold, malignancy within the past 5 years (not including basal cell or squamous cell skin cancer), severe movement disorder (i.e. Parkinson's disease), deep vein thrombosis, or multiple sclerosis.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    Arm 1: Assessments and questionnaires only

    Complete questionnaires on RLS and pain Stimulation: H-reflex - A small electrical stimulus is provided to the leg and foot area and a measurement of the stimulus is taken by the EEG electrodes. Somatosensory evoked potential (SSEP) - A small electrical stimulus is provided to a nerve on the body and measured at several places along the nervous system (spinal cord, brain, etc.) with the EMG and EEG electrodes. Vibratory Electrophysiological Response Potential (ERP) - stimulation of the ankle with vibration sensations using a device like a buzzer and recording of body's responses using the EEG and/or EMG electrodes. Transcranial Magnetic Stimulation (TMS) - A small magnetic pulse is used to provide a small amount of electrical stimulation to nervous system. The EEG and/or EMG electrodes will be used to measure body's reaction.

    Other: H-Reflex · Other: Somatosensory evoked potential (SSEP) · Other: Vibratory Electrophysiological Response Potential (ERP) · Other: Transcranial Magnetic Stimulation (TMS)

  • Active comparator
    Arm 2: Off-on-off

    Participants will turn OFF their SCS at least 48 hours prior to the visit. The assessments listed in Arm 1 will be performed and the SCS will be turned ON for at least 60 minutes before repeating the assessments. Participants may repeat the questionnaires during this waiting period. Finally, the SCS is turned OFF again, this time for at least 30 minutes before repeating the assessments, except for the h-reflex, which will not be needed again. As with before, participants can complete the questionnaires during this waiting period.

    Other: H-Reflex · Other: Somatosensory evoked potential (SSEP) · Other: Vibratory Electrophysiological Response Potential (ERP) · Other: Transcranial Magnetic Stimulation (TMS) · Other: Spinal Cord Stimulator (SCS) manipulation

  • Active comparator
    Arm 3: Off-on-off post-op

    Participants will perform the same procedures as those in Arm 2, but only after 2-3 weeks from receiving a permanent SCS.

    Other: H-Reflex · Other: Somatosensory evoked potential (SSEP) · Other: Vibratory Electrophysiological Response Potential (ERP) · Other: Transcranial Magnetic Stimulation (TMS) · Other: Spinal Cord Stimulator (SCS) manipulation

  • Active comparator
    Arm 4: On-off-on

    Participants will have their SCS on for at least 48 hours prior to the visit. The assessments listed in Arm 1 will be performed and the SCS will be turned Off for at least 60 minutes before repeating the assessments. Participants may repeat the questionnaires during this waiting period. Finally, the SCS is turned On again, this time for at least 30 minutes before repeating the assessments, except for the h-reflex, which will not be needed again. As with before, participants can complete the questionnaires during this waiting period.

    Other: H-Reflex · Other: Somatosensory evoked potential (SSEP) · Other: Vibratory Electrophysiological Response Potential (ERP) · Other: Transcranial Magnetic Stimulation (TMS) · Other: Spinal Cord Stimulator (SCS) manipulation

Interventions

  • OtherH-Reflex

    H-reflex - A small electrical stimulus is provided to the leg and foot area and a measurement of the stimulus is taken by the EEG electrodes.

  • OtherSomatosensory evoked potential (SSEP)

    A small electrical stimulus is provided to a nerve on the body and measured at several places along the nervous system (spinal cord, brain, etc.) with the EMG and EEG electrodes.

  • OtherVibratory Electrophysiological Response Potential (ERP)

    stimulation is provided to the ankle with vibration sensations using a device like a buzzer and the recording of the body's responses using the EEG and/or EMG electrodes.

  • OtherTranscranial Magnetic Stimulation (TMS)

    A small magnetic pulse is used to provide a small amount of electrical stimulation to the nervous system. The EEG and/or EMG electrodes will be used to measure the body's reaction.

  • OtherSpinal Cord Stimulator (SCS) manipulation

    Spinal cord stimulator will be turned on/off

06

What researchers measure

Primary outcomes

  1. Changes in H-reflex neurophysiological activity in response to Spinal Cord Stimulation (SCS)

    Time frame: Up to 3 Weeks after consent to the study

  2. Changes in Somatosensory Evoked Potential (SSEP) activity in response to Spinal Cord Stimulation (SCS)

    Time frame: Up to 3 Weeks after consent to the study

  3. Changes in Vibratory Electrophysiological Response Potential (ERP) activity in response to Spinal Cord Stimulation (SCS)

    Time frame: Up to 3 Weeks after consent to the study

  4. Changes in Transcranial Magnetic Stimulation (TMS) activity in response to Spinal Cord Stimulation (SCS)

    Time frame: Up to 3 Weeks after consent to the study

Secondary outcomes

  1. Changes in self-reported RLS symptoms via International Restless Legs Syndrome (IRLSS) Questionnaire

    Time frame: Up to 3 Weeks after consent to the study

  2. Changes in self-reported pain symptoms via Promis Questionnaire

    Time frame: Up to 3 Weeks after consent to the study

  3. Changes in self-reported pain symptoms via PainDetect Questionnaire

    Time frame: Up to 3 Weeks after consent to the study

07

Study locations

1 of 1 sites recruiting
  • University of Alabama at Birmingham
    Birmingham, Alabama 35233, United States
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07179406
Lead sponsor
University of Alabama at Birmingham
Responsible party
Marshall Holland (Assistant Professor, University of Alabama at Birmingham) — Principal investigator
First posted
Sep 17, 2025
Start date
Aug 4, 2025
Primary completion
Jan 31, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Jun 26, 2026

Study contacts

Marshall Holland, MD
Contact
mtholland@uabmc.edu
2059343411

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion